103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

NeurologyLive® Mind Moments®

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, William Gallentine, DO, interim chief of pediatric neurology at Stanford Medicine Children’s Health, who discussed several topics related to the advances in pediatric epilepsy, epilepsy surgery, and seizure localization. Gallentine, who also serves as a clinical professor, provided insight on the screening process and eligibility criteria for epilepsy surgery, as well as the importance of lifestyle modifications when treating epilepsy. Furthermore, he touched upon the genetic background of certain epileptic disorders and when the clinical community can expect gene therapies.
Looking for more epilepsy discussion? Check out the NeurologyLive® epilepsy clinical focus page.
Episode Breakdown:

• 1:10 – State of pediatric epilepsy
• 2:15 – Screening potential candidates for epilepsy surgery
• 5:00 – Advances in seizure localization
• 7:15 – Neurology News Minute
• 9:25 – Balance of nonpharmacological approaches
• 11:20 – Realistic timeline of gene therapies for epilepsy
• 13:15 – Future plans for research, current unmet needs

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• FDA Clears AI-Powered Brain MRI Software Pixyl.Neuro

• FDA Grants Meeting With BrainStorm Cell Therapeutics on ALS Therapy NurOwn

• FDA Warns of Serious Adverse Effects for Using Levetiracetam and Clobazam in Epilepsy

Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.